TransEnterix (NYSE:TRXC) said today that it inked a deal to sell up to $25 million worth of stock to Lincoln Park Capital Fund over 3 years. Research Triangle Park, N.C-based TransEnterix said the deal values any sales based on its share price at the time. The company markets a robot-assisted surgery platform that incorporates haptics and eye-tracking technology called Senhance. […]
TransEnterix
TransEnterix opens robot-assisted surgery training and R&D center in Milan
TransEnterix (NYSE:TRXC) said today it opened a new robotic surgery training and research & development center in Milan, Italy. The facility, named the TransEnterix Milan Robotic Surgery Center, was inaugurated yesterday in a special ceremony, the Research Triangle, N.C.-based company said. The new facilities will feature an integrated demonstration operating theater, robotic training and development systems […]
TransEnterix bets on haptics for Senhance robot-assisted surgery device
TransEnterix (NYSE:TRXC) is betting that the haptics technology in its Senhance robot-assisted surgery platform will help it make headway against Intuitive Surgical (NSDQ:ISRG) and its 10-year lead on the market. CEO Todd Pope told MassDevice.com that the Senhance’s haptics – the system’s ability to convey a sense of touch and resistance to the surgeon – are an […]
TransEnterix inks distribution deal Down Under for Senhance surgical robot
TransEnterix (NYSE:TRXC) said today it signed an distribution deal with Getz Healthcare for its Senhance surgical robotics system. The deal will position Getz Healthcare as the exclusive distributor of the Senhance system in the Australian and New Zealand markets, according to Morrisville, N.C.-based TransEnterix. “Australia and New Zealand are key markets in the healthcare industry, with […]
TransEnterix reboots ALF-X robot-assisted surgery platform as Senhance
TransEnterix (NYSE:TRXC) said today it is rebranding its ALF-X robotic surgical system as the Senhance surgical robotic system. The company said it made the switch to the new name and logo, which features a thumb-print combined with circuity, as a representation of the connection between surgeon and technology that the robotic system provides. “We are pleased […]
TransEnterix sees light on Q2 release, shares tick up
TransEnterix (NYSE:TRXC) hasn’t had the best luck in 2016, with the FDA denying its 510(k) clearance submission in April and shareholders suing the company in June over the nixed project, but things are looking up for the robotics company with the release of 2nd quarter earnings that beat the street and sent shares up nearly 7%. […]
TransEnterix sells 1st ALF-X unit
TransEnterix (NYSE:TRXC) said today it sold the 1st ALF-X surgical robotic system to Milan, Italy’s Humanitas Hospital. The company acquired the Telelap ALF-X robot-assisted surgery device from Italy’s Sofar SpA last September. The Telelap ALF-X device has CE Mark approval in the European Union for minimally invasive surgery procedures. “We are pleased to announce the first […]
New crop of robots to vie for space in the operating room
(Reuters) – Even though many doctors see need for improvement, surgical robots are poised for big gains in operating rooms around the world. Within 5 years, 1 in 3 U.S. surgeries – more than double current levels – is expected to be performed with robotic systems, with surgeons sitting at computer consoles guiding mechanical arms. Companies developing new […]
Shareholders sue TransEnterix over shelved SurgiBot
TransEnterix (NYSE:TRXC) said today that it’s being sued by a pair of shareholders over its failure to win FDA clearance for the SurgiBot robot-assisted surgery device. Research Triangle Park, N.C.-based TransEnterix’s shares plunged during the spring, after it revealed in April that the FDA denied its 510(k) application for SurgiBot, saying that the platform didn’t meet the criteria for substantial […]
Novartis pharma head Epstein steps away, most recent in string of top-level turnovers | Personnel Moves, May 27, 2015
Novartis pharma head Epstein steps away, most recent loss in string of top-level turnovers Novartis (NYSE:NVS) is facing an upheaval in its top management, seeing 7 departures over the last 5 months as shares fell 25% since last July. Last week, Novartis pharmaceuticals head David Epstein quit as his division was split up. Earlier in the month, U.S. […]
TransEnterix shelves SurgiBot after FDA denial, turns to ALF-X
TransEnterix (NYSE:TRXC) is shelving its SurgiBot robot-assisted surgery platform and focusing on the ALF-X platform it acquired last year. Stock prices for the Research Triangle Park, N.C.-based plunged last month when TransEnterix revealed that the FDA denied its submission for 510(k) clearance for the SurgiBot, which it claims as the 1st patient-side robotically enhanced laparoscopy platform designed […]
